The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
Mortality in schizophrenia.
Abstract
PURPOSE: The purpose of this article is to describe the current status of knowledge on excess mortality in schizophrenia and its causative factors, and to expand upon previous work evaluating approaches that may reduce mortality rates. METHODS: Literature available since 1995 was identified in a computerized search of the bibliographical databases Medline and Embase, using the topics 'mortality' and 'schizophrenia', and in a cross-reference search for articles that were particularly relevant. RESULTS: Schizophrenia is associated with mortality rates that are two to three times higher than those expected or observed in the general population. This excess of mortality is accounted for by a combination of an increased risk of suicide, in particular in young male patients soon after diagnosis, and more importantly, a higher number of natural deaths. In order to diminish the level of suicide among people with schizophrenia, the majority of research has focused on the identification of risk factors that predispose patients to attempt or commit suicide, while unhealthy styles, polypharmacy and inadequate healthcare have been shown to contribute to the high natural mortality. The link between the use of antipychotics and mortality has not been yet clarified. CONCLUSION: Dramatically increased mortality of schizophrenia patients is well established. It is time to move beyond this topic, and work towards interventions that aim at reducing the mortality risk in such patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Long-term antipsychotic use and adverse lifestyle choices (e.g. obesity, smoking, poor diet, illicit drug use, and physical inactivity) are implicated in increased risk of cardiovascular events in these populations [3], [19], [20], [22], [31]–[33]”
From Life Expectancy at Birth for People with Serious Mental Illness and Other Major Disorders from a Secondary Mental Health Care Case Register in London (2011) · cites this paper as [19]
Citations
Cites
Ford, E. S., Giles, W. H., & Dietz, W. H. (2002) · JAMA · doi:10.1001/jama.287.3.356 · Cited by 6,698
The Disease Burden Associated With Overweight and Obesity
Must, A. (1999) · JAMA · doi:10.1001/jama.282.16.1523 · Cited by 4,827
Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome
Isomaa, B., Almgren, P., Tuomi, T., Forsén, B., Lahti, K., Nissén, M., Taskinen, M.-R., & Groop, L. (2001) · Diabetes Care · doi:10.2337/diacare.24.4.683 · Cited by 4,760
Suicide as an outcome for mental disorders: A meta-analysis
Harris, E. C., & Barraclough, B. (1997) · British Journal of Psychiatry · doi:10.1192/bjp.170.3.205 · Cited by 2,589
Antipsychotic-induced weight gain: a comprehensive research synthesis
Allison, D. B., Mentore, J. L., Heo, M., Chandler, L. P., Cappelleri, J. C., Infante, M. C., & Weiden, P. J. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.11.1686 · Cited by 2,382
Excess mortality of mental disorder
Harris, C., & Barraclough, B. (1998) · British Journal of Psychiatry · doi:10.1192/bjp.173.1.11 · Cited by 1,881
Annual Deaths Attributable to Obesity in the United States
Allison, D. B. (1999) · JAMA · doi:10.1001/jama.282.16.1530 · Cited by 1,863
Consensus development conference on antipsychotic drugs and obesity and diabetes
American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, & North American Association for the Study of Obesity (2004) · Diabetes Care · doi:10.2337/diacare.27.2.596 · Cited by 1,554
Alexander, C. M., Landsman, P. B., Teutsch, S. M., & Haffner, S. M. (2003) · Diabetes · doi:10.2337/diabetes.52.5.1210 · Cited by 1,475 · cited 1×
“The syndrome has been associated with an increased risk for cardiovascular morbidity and mortality.(25,26) Patients with schizophrenia would seem to have a two-fold higher relative risk of developing coronary heart disease (CHD) compared with the general population.”
BackgroundDiscovering the Neural Basis of Human Social Anxiety: A Diagnostic and Therapeutic Imperative
Charney, D. S. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.1.1 · Cited by 1,428
Meltzer, H. Y. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.1.82 · Cited by 1,393
Mcevoy, J., Meyer, J., Goff, D., Nasrallah, H., Davis, S., Sullivan, L., Meltzer, H., Hsiao, J. K., Stroup, T., & Lieberman, J. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.07.014 · Cited by 1,220
Consensus Development Conference on Antipsychotic Drugs and Obesity and Diabetes
Boehm, G., Racoosin, J. A., LAUGHREN, T. P., & Katz, R. G. (2004) · Diabetes Care · doi:10.2337/diacare.27.8.2088-a · Cited by 1,204
Causes of the excess mortality of schizophrenia
Brown, S., Inskip, H., & Barraclough, B. (2000) · British Journal of Psychiatry · doi:10.1192/bjp.177.3.212 · Cited by 1,087
Schizophrenia and increased risks of cardiovascular disease
Hennekens, C. H., Hennekens, A. R., Hollar, D., & Casey, D. E. (2005) · American Heart Journal · doi:10.1016/j.ahj.2005.02.007 · Cited by 1,070
The Lifetime Risk of Suicide in Schizophrenia: A Reexamination
Palmer, B. A., Pankratz, V. S., & Bostwick, J. M. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.3.247 · Cited by 1,026
The unhealthy lifestyle of people with schizophrenia
Brown, S., Birtwistle, J., ROE, L., & THOMPSON, C. (1999) · Psychological Medicine · doi:10.1017/s0033291798008186 · Cited by 880
Excess mortality of schizophrenia: A meta-analysis
Brown, S. (1997) · British Journal of Psychiatry · doi:10.1192/bjp.171.6.502 · Cited by 869
Schizophrenia and suicide: Systematic review of risk factors
Hawton, K. E., Sutton, L., Haw, C., Sinclair, J., & Deeks, J. J. (2005) · The British Journal of Psychiatry · doi:10.1192/bjp.187.1.9 · Cited by 808
Practice Guideline for the Treatment of Patients With Schizophrenia Second Edition
(2007) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9780890423363.45859 · Cited by 735
Mortality and causes of death in schizophrenia in Stockholm County, Sweden
Ösby, U., Correia, N., Brandt, L., Ekbom, A., & Sparén, P. (2000) · Schizophrenia Research · doi:10.1016/s0920-9964(99)00191-7 · Cited by 679
Mental Disorders and Use of Cardiovascular Procedures After Myocardial Infarction
Druss, B. G. (2000) · JAMA · doi:10.1001/jama.283.4.506 · Cited by 541
Schizophrenics Kill Themselves Too: A Review of Risk Factors for Suicide
Caldwell, C. B., & Gottesman, I. I. (1990) · Schizophrenia Bulletin · doi:10.1093/schbul/16.4.571 · Cited by 511
Troiano, R. P., Frongillo, E. A., Sobal, J., & Levitsky, D. A. (1996) · PubMed · Cited by 472
Antipsychotics and the Risk of Sudden Cardiac Death
Ray, W. A., Meredith, S. K., Thapa, P. B., Meador, K. G., Hall, K., & Murray, K. T. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.12.1161 · Cited by 437
Mortality and Causes of Death in First Admitted Schizophrenic Patients
Mortensen, P. B., & Juel, K. (1993) · The British Journal of Psychiatry · doi:10.1192/bjp.163.2.183 · Cited by 412
Practice Guideline for the Assessment and Treatment of Patients With Suicidal Behaviors
(2007) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9780890423363.56008 · Cited by 405
Schizophrenia, neuroleptic medication and mortality
Joukamaa, M., Heliövaara, M., Knekt, P., Aromaa, A., Raitasalo, R., & Lehtinen, V. (2006) · British Journal of Psychiatry · doi:10.1192/bjp.188.2.122 · Cited by 395
The Distribution of Body Mass Index Among Individuals With and Without Schizophrenia
Allison, D. B., Fontaine, K. R., Heo, M., Mentore, J. L., Cappelleri, J. C., Chandler, L. P., Weiden, P. J., & Cheskin, L. J. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0402 · Cited by 390
Mortality in a Cohort of Patients with Schizophrenia: A Record Linkage Study*
Newman, S. C., & Bland, R. C. (1991) · The Canadian Journal of Psychiatry · doi:10.1177/070674379103600401 · Cited by 372
Duration of untreated psychosis in first-episode schizophrenia: marker or determinant of course?
McGlashan, T. H. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00084-0 · Cited by 366
Gelenberg, A. J. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0101 · Cited by 355
Suicidal Behavior in Patients With Schizophrenia and Other Psychotic Disorders
Radomsky, E. D., Haas, G. L., Mann, J. J., & Sweeney, J. A. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.10.1590 · Cited by 349
Mental disorders and cause-specific mortality
Joukamaa, M., HeliöVaara, M., Knekt, P., Aromaa, A., Raitasalo, R., & Lehtinen, V. (2001) · British Journal of Psychiatry · doi:10.1192/bjp.179.6.498 · Cited by 328
Symptoms, subtype, and suicidality in patients with schizophrenia spectrum disorders
Fenton, W. S., McGlashan, T. H., Victor, B. J., & Blyler, C. R. (1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.2.199 · Cited by 325
Medical Morbidity and Mortality in Schizophrenia
GOFF, D. C., Cather, C., Evins, A. E., Henderson, D. C., Freudenreich, O., Copeland, P. M., Bierer, M. F., Duckworth, K. S., & Sacks, F. M. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0205 · Cited by 312
Predisposition to Addiction: Pharmacokinetics, Pharmacodynamics, and Brain Circuitry
Kalivas, P. W. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.1.1 · Cited by 301
A placebo controlled trial of bupropion for smoking cessation in schizophrenia
George, T. P., Vessicchio, J. C., Termine, A., Bregartner, T. A., Feingold, A., Rounsaville, B. J., & Kosten, T. R. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01339-2 · Cited by 291
Waddington, J. L., Youssef, H. A., & Kinsella, A. (1998) · The British Journal of Psychiatry · doi:10.1192/bjp.173.4.325 · Cited by 268
Schizophrenia and Substance Abuse
Smith, J. E., & Hucker, S. J. (1994) · The British Journal of Psychiatry · doi:10.1192/bjp.165.1.13 · Cited by 266
Early Detection of the First Episode of Schizophrenia and Suicidal Behavior
Melle, I. S., Johannesen, J. O., Friis, S., Haahr, U., Joa, I., Larsen, T. K., Opjordsmoen, S., Rund, B. R., Simonsen, E. H., Vaglum, P., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.5.800 · Cited by 249
Bodyweight Gain with Atypical Antipsychotics
Wetterling, T. (2001) · Drug Safety · doi:10.2165/00002018-200124010-00005 · Cited by 231
Time trends in schizophrenia mortality in Stockholm county, Sweden: cohort study
Osby, U. (2000) · BMJ · doi:10.1136/bmj.321.7259.483 · Cited by 220
QTc interval prolongation and antipsychotic drug treatments: focus on sertindole
Lindström, E., Farde, L., Eberhard, J., & Haverkamp, W. (2005) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145705005250 · Cited by 207
Evins, A. E., Mays, V. K., Rigotti, N. A., Tisdale, T., Cather, C., & Goff, D. C. (2001) · Nicotine & Tobacco Research · doi:10.1080/14622200110073920 · Cited by 191
Stahl, S. M., & Grady, M. J. W. (2004) · Current Medicinal Chemistry · doi:10.2174/0929867043456070 · Cited by 186
CLINICAL PRACTICE GUIDELINES Treatment of Schizophrenia
Paris, J., Bland, R. C., Goldbloom, D. S., Grof, P., LESAGE, A. D., Streiner, D. L., Addington, D. E., Arboleda‐Flórez, J., Benkelfat, C., Bond, M., et al. (2005) · Cited by 184
Cause-specific mortality in psychiatric patients after deinstitutionalisation
Hansen, V., Jacobsen, B. K., & Arnesen, E. (2001) · The British Journal of Psychiatry · doi:10.1192/bjp.179.5.438 · Cited by 149
Kendrick, T. (1996) · British Journal of Psychiatry · doi:10.1192/bjp.169.6.733 · Cited by 145
Antipsychotic Polypharmacy, Part 1: Therapeutic Option or Dirty Little Secret?
Stahl, S. M. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0701 · Cited by 144
Mortality and causes of death in schizophrenic patients in Denmark
Mortensen, P. B., & Juel, K. (1990) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1990.tb05466.x · Cited by 138
High prevalence of the metabolic syndrome among a Swedish cohort of patients with schizophrenia
Hägg, S., Lindblom, Y., Mjörndal, T., & Adolfsson, R. (2006) · International Clinical Psychopharmacology · doi:10.1097/01.yic.0000188215.84784.17 · Cited by 137
Centorrino, F., Baldessarini, R. J., Kando, J. C., Frankenburg, F. R., Volpicelli, S. A., & Flood, J. G. (1994) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199404000-00006 · Cited by 131
Prolongation of QT Interval in Isolated Feline Hearts by Antipsychotic Drugs
Drici, M., Wang, W. X., Liu, X., Woosley, R. L., & Flockhart, D. A. (1998) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199812000-00011 · Cited by 131
Polypharmacy and excessive dosing: Psychiatrists' perceptions of antipsychotic drug prescription
Ito, H., Koyama, A., & Higuchi, T. (2005) · The British Journal of Psychiatry · doi:10.1192/bjp.187.3.243 · Cited by 130
Schizophrenia and Deliberate Self‐Harm: A Systematic Review of Risk Factors
Haw, C., Hawton, K. E., Sutton, L., Sinclair, J., & Deeks, J. J. (2005) · Suicide and Life-Threatening Behavior · doi:10.1521/suli.35.1.50.59260 · Cited by 128
Prevalence of Obesity in Patients Receiving Depot Antipsychotics
Silverstone, T., Smith, G., & Goodall, E. (1988) · The British Journal of Psychiatry · doi:10.1192/bjp.153.2.214 · Cited by 125
Case register study of suicide risk in mental disorders
Baxter, D. N., & Appleby, L. (1999) · The British Journal of Psychiatry · doi:10.1192/bjp.175.4.322 · Cited by 117
Suicidal behaviour in early psychosis
Addington, J., Williams, J. L., Young, J. A., & Addington, D. E. (2004) · Acta Psychiatrica Scandinavica · doi:10.1046/j.0001-690x.2003.00232.x · Cited by 113
Mortality among patients with schizophrenia and reduced psychiatric hospital care
Heilä, H., Haukka, J. K., Suvisaari, J., & Lönnqvist, J. K. (2005) · Psychological Medicine · doi:10.1017/s0033291704004118 · Cited by 109
Attempted suicide in chronic schizophrenia
Roy, A., Mazonson, A., & Pickar, D. (1984) · The British Journal of Psychiatry · doi:10.1192/bjp.144.3.303 · Cited by 101
We Can Talk: Individual Psychotherapy for Schizophrenia
Fenton, W. S. (1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.11.1493 · Cited by 101
Suicidal indicators in schizophrenia
Dassori, A. M., Mezzich, J. E., & Keshavan, M. S. (1990) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1990.tb05472.x · Cited by 73
Montout, C., Casadebaig, F., Lagnaoui, R., Verdoux, H., Philippe, A., Bégaud, B., & Moore, N. D. (2002) · Schizophrenia Research · doi:10.1016/s0920-9964(01)00325-5 · Cited by 69
A clinical and epidemiological survey of parasuicide and suicide in Edinburgh schizophrenics
Wilkinson, G., & Bacon, N. A. (1984) · Psychological Medicine · doi:10.1017/s0033291700019863 · Cited by 68
Cardiovascular Procedures in Patients With Mental Disorders
Young, J. K., & Foster, D. A. (2000) · JAMA · doi:10.1001/jama.283.24.3198-c · Cited by 65
Suicide in Schizophrenia, Clozapine, and Adoption of Evidence-Based Medicine
Meltzer, H. Y. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0417 · Cited by 63
The Distribution of Adipose Tissue in Female In-patients Receiving Psychotropic Drugs
STEDMAN, T. J., & Welham, J. (1993) · The British Journal of Psychiatry · doi:10.1192/bjp.162.2.249 · Cited by 56
Mortality in chronic schizophrenia during decreasing number of psychiatric beds in Finland
Salokangas, R. K. R. (2002) · Schizophrenia Research · doi:10.1016/s0920-9964(01)00281-x · Cited by 55
[Mortality in schizophrenic patients. 3 years follow-up of a cohort].
Casadebaig, F., & Philippe, A. (1999) · PubMed · Cited by 46
Clinical correlates of antipsychotic polytherapy in patients with schizophrenia in Singapore
Sim, K., Su, A., Chan, Y. H., Shinfuku, N., Kua, E. H., & Tan, C. H. (2004) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2004.01239.x · Cited by 32
Épidémiologie des troubles schizophréniques
Hautecouverture, S., Limosin, F., & Rouillon, F. (2006) · La Presse Médicale · doi:10.1016/s0755-4982(06)74620-6 · Cited by 27
Cardiovascular Effects of Novel Antipsychotic Medications
Feinstein, R. E. (2002) · Heart Disease · doi:10.1097/00132580-200205000-00009 · Cited by 27
Dombrovski, A. Y., & Rosenstock, J. B. (2004) · Current Opinion in Psychiatry · doi:10.1097/00001504-200411000-00018 · Cited by 24
Antipsychotics and sudden death: Is thioridazine the only bad actor?
Ray, W. A., & Meador, K. G. (2002) · The British Journal of Psychiatry · doi:10.1192/bjp.180.6.483 · Cited by 24
Screening Mammography in Elderly Women—Reply
Kerlikowske, K. M. (2000) · JAMA · doi:10.1001/jama.283.24.3198 · Cited by 19
The Economics of Treating Obesity
Hutton, J. (1994) · PharmacoEconomics · doi:10.2165/00019053-199400051-00014 · Cited by 14
Flagged first, then by citations
Research works printed but not linked: 1
- Casey DE, 2004, Antipsychotic‐induced weight gain and metabolic abnormalities: implications for increased mortality in patients with schizophrenia, J Clin Psychiatry, 65, 4
Cited by
Sorted by citations
Schizophrenia, “just the facts” 4. Clinical features and conceptualization
Tandon, R., Nasrallah, H. A., & Keshavan, M. S. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2009.03.005 · Cited by 1,101
“Age-standardized mortality rates among persons with schizophrenia are approximately double that of the general population and their lifespan is abbreviated by approximately 15–20 years (Parks et al., 2006; Auquier et al., 2007).”
Chang, C.-K., Hayes, R. D., Perera, G., Broadbent, M. T. M., Fernandes, A. C., Lee, W. E., Hotopf, M., & Stewart, R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019590 · Cited by 714
“Preliminary strategies for preventing premature deaths among people with SMI have been suggested, emphasizing the management of suicide risk and physical illness, minimum polypharmacy, and improvement of accessibility to physical health care [19].”
BackgroundBarnes, T. R. E., Drake, R., Paton, C., Cooper, S. J., Deakin, J. F. W., Ferrier, I. N., Gregory, C. J., Haddad, P. M., Howes, O. D., Jones, I. R., et al. (2019) · Journal of Psychopharmacology · doi:10.1177/0269881119889296 · Cited by 615
Correll, C. U., Rummel-Kluge, C., Corves, C., Kane, J. M., & Leucht, S. (2008) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn018 · Cited by 406
Schizophrenia, neuroleptic medication and mortality
Joukamaa, M., Heliövaara, M., Knekt, P., Aromaa, A., Raitasalo, R., & Lehtinen, V. (2006) · British Journal of Psychiatry · doi:10.1192/bjp.188.2.122 · Cited by 395
Metadata
- Authors
- Auquier, P., Lançon, C., Rouillon, F., Lader, M., & Holmes, C.
- Affiliations
- Hôpital de la Timone (FR)
- Hôpital Sainte-Marguerite (FR)
- Centre Hospitalier Sainte-Anne (FR)
- Corresponding author
- Auquier, Pascal
- Venue
- Pharmacoepidemiology and Drug Safety
- Publisher
- Wiley
- Published
- 2006-10-23
- Volume
- 15
- Issue
- 12
- Pages
- 873-879
- ISSN
- 1053-8569 (ISSN-L)
- 1099-1557
- OpenAlex
- W2097031522
- Cited by
- 249
- References
- 77
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 2 · 2023: 7 · 2022: 6 · 2021: 8 · 2020: 5 · 2019: 10 · 2018: 4 · 2017: 4 · 2016: 8 · 2015: 11 · 2014: 13 · 2013: 20 · 2012: 27
- FWCI
- 3.19
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Pharmacoepidemiology and Drug Safety (publishedVersion)
- PubMed (publishedVersion)
- Funders
- H. Lundbeck A/S
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Social Sciences › Psychology › Clinical Psychology › Suicide and Self-Harm Studies
- Social Sciences › Arts and Humanities › Philosophy › Mental Health and Psychiatry
- Keywords
- schizophrenia, excess mortality, suicide risk, natural mortality, risk factors, polypharmacy, antipsychotic drugs, quality of care
- MeSH terms
- Cardiovascular Diseases, Cause of Death, Health Services Accessibility, Humans, Risk, Schizophrenia, Suicide, Antipsychotic Agents, Violence, Harm Reduction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review